Amisulprid is indicated for the treatment of acute and chronic schizophrenic disorders in which positive symptoms (such as delusions, hallucinations and thought disorders) and/or negative symptoms (such as blunted effect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

This is only the preview. Please check here for the full indication.

Anatomical Therapeutic Chemical: N
Dosage form: Tablet
Packaging: 7's x 4
Therapeutic area: Active pharmaceutical ingredient: